158 related articles for article (PubMed ID: 35834819)
1. From 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624) to Selective Small-Molecule Antagonists of Human α9α10 Nicotinic Receptor by Modifications at the Ammonium Ethyl Residue.
Bavo F; Pallavicini M; Pucci S; Appiani R; Giraudo A; Eaton B; Lucero L; Gotti C; Moretti M; Whiteaker P; Bolchi C
J Med Chem; 2022 Jul; 65(14):10079-10097. PubMed ID: 35834819
[TBL] [Abstract][Full Text] [Related]
2. Subnanomolar Affinity and Selective Antagonism at α7 Nicotinic Receptor by Combined Modifications of 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624).
Bavo F; Pallavicini M; Pucci S; Appiani R; Giraudo A; Oh H; Kneisley DL; Eaton B; Lucero L; Gotti C; Clementi F; Whiteaker P; Bolchi C
J Med Chem; 2023 Jan; 66(1):306-332. PubMed ID: 36526469
[TBL] [Abstract][Full Text] [Related]
3. Potent Antiglioblastoma Agents by Hybridizing the Onium-Alkyloxy-Stilbene Based Structures of an α7-nAChR, α9-nAChR Antagonist and of a Pro-Oxidant Mitocan.
Bavo F; Pucci S; Fasoli F; Lammi C; Moretti M; Mucchietto V; Lattuada D; Viani P; De Palma C; Budriesi R; Corradini I; Dowell C; McIntosh JM; Clementi F; Bolchi C; Gotti C; Pallavicini M
J Med Chem; 2018 Dec; 61(23):10531-10544. PubMed ID: 30403486
[TBL] [Abstract][Full Text] [Related]
4. Evidence of a dual mechanism of action underlying the anti-proliferative and cytotoxic effects of ammonium-alkyloxy-stilbene-based α7- and α9-nicotinic ligands on glioblastoma cells.
Pucci S; Bolchi C; Bavo F; Pallavicini M; De Palma C; Renzi M; Fucile S; Benfante R; Di Lascio S; Lattuada D; Bessereau JL; D'Alessandro M; Risson V; Zoli M; Clementi F; Gotti C
Pharmacol Res; 2022 Jan; 175():105959. PubMed ID: 34756924
[TBL] [Abstract][Full Text] [Related]
5. Small molecule ligands for α9 * and α7 nicotinic receptors: A survey and an update, respectively.
Giraudo A; Pallavicini M; Bolchi C
Pharmacol Res; 2023 Jul; 193():106801. PubMed ID: 37236412
[TBL] [Abstract][Full Text] [Related]
6. Selective Agonists and Antagonists of α9 Versus α7 Nicotinic Acetylcholine Receptors.
Papke RL; Andleeb H; Stokes C; Quadri M; Horenstein NA
ACS Chem Neurosci; 2022 Mar; 13(5):624-637. PubMed ID: 35167270
[TBL] [Abstract][Full Text] [Related]
7. Drugs selective for nicotinic receptor subtypes: a real possibility or a dream?
Gotti C; Carbonnelle E; Moretti M; Zwart R; Clementi F
Behav Brain Res; 2000 Aug; 113(1-2):183-92. PubMed ID: 10942044
[TBL] [Abstract][Full Text] [Related]
8. α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.
Mucchietto V; Fasoli F; Pucci S; Moretti M; Benfante R; Maroli A; Di Lascio S; Bolchi C; Pallavicini M; Dowell C; McIntosh M; Clementi F; Gotti C
Br J Pharmacol; 2018 Jun; 175(11):1957-1972. PubMed ID: 28726253
[TBL] [Abstract][Full Text] [Related]
9. Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10.
Zakrzewicz A; Richter K; Agné A; Wilker S; Siebers K; Fink B; Krasteva-Christ G; Althaus M; Padberg W; Hone AJ; McIntosh JM; Grau V
Front Cell Neurosci; 2017; 11():189. PubMed ID: 28725182
[TBL] [Abstract][Full Text] [Related]
10. MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.
Brown KC; Lau JK; Dom AM; Witte TR; Luo H; Crabtree CM; Shah YH; Shiflett BS; Marcelo AJ; Proper NA; Hardman WE; Egleton RD; Chen YC; Mangiarua EI; Dasgupta P
Angiogenesis; 2012 Mar; 15(1):99-114. PubMed ID: 22198237
[TBL] [Abstract][Full Text] [Related]
11. Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor.
Maggi L; Palma E; Eusebi F; Moretti M; Balestra B; Clementi F; Gotti C
Br J Pharmacol; 1999 Jan; 126(1):285-95. PubMed ID: 10051147
[TBL] [Abstract][Full Text] [Related]
12. Oligoarginine Peptides, a New Family of Nicotinic Acetylcholine Receptor Inhibitors.
Lebedev DS; Kryukova EV; Ivanov IA; Egorova NS; Timofeev ND; Spirova EN; Tufanova EY; Siniavin AE; Kudryavtsev DS; Kasheverov IE; Zouridakis M; Katsarava R; Zavradashvili N; Iagorshvili I; Tzartos SJ; Tsetlin VI
Mol Pharmacol; 2019 Nov; 96(5):664-673. PubMed ID: 31492697
[TBL] [Abstract][Full Text] [Related]
13. Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.
Indurthi DC; Pera E; Kim HL; Chu C; McLeod MD; McIntosh JM; Absalom NL; Chebib M
Biochem Pharmacol; 2014 May; 89(1):131-40. PubMed ID: 24548457
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain.
Romero HK; Christensen SB; Di Cesare Mannelli L; Gajewiak J; Ramachandra R; Elmslie KS; Vetter DE; Ghelardini C; Iadonato SP; Mercado JL; Olivera BM; McIntosh JM
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1825-E1832. PubMed ID: 28223528
[TBL] [Abstract][Full Text] [Related]
15. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro.
Koval L; Lykhmus O; Zhmak M; Khruschov A; Tsetlin V; Magrini E; Viola A; Chernyavsky A; Qian J; Grando S; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2011 Apr; 43(4):516-24. PubMed ID: 21146628
[TBL] [Abstract][Full Text] [Related]
17. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
Mohammadi SA; Christie MJ
Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047
[TBL] [Abstract][Full Text] [Related]
18. Discovery of non-peptide, small molecule antagonists of α9α10 nicotinic acetylcholine receptors as novel analgesics for the treatment of neuropathic and tonic inflammatory pain.
Zheng G; Zhang Z; Dowell C; Wala E; Dwoskin LP; Holtman JR; McIntosh JM; Crooks PA
Bioorg Med Chem Lett; 2011 Apr; 21(8):2476-9. PubMed ID: 21397497
[TBL] [Abstract][Full Text] [Related]
19. New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold.
Dallanoce C; Richter K; Stokes C; Papotto C; Andleeb H; Thakur GA; Kerr A; Grau V; Papke RL
ACS Chem Neurosci; 2024 Feb; 15(4):827-843. PubMed ID: 38335726
[TBL] [Abstract][Full Text] [Related]
20. α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain.
Shelukhina I; Siniavin A; Kasheverov I; Ojomoko L; Tsetlin V; Utkin Y
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
